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During thymus-dependent (TD) responses, 
B cells that make cognate interactions with 
T cells in the outer T zone of secondary lym-
phoid tissues can differentiate along either 
follicular or extrafollicular pathways. In the fol-
licular pathway, activated B cells form the 
germinal center (GC), where they undergo so-
matic hypermutation, selection, and eventually 
exit as high affinity long-lived plasma cells or 
memory B cells (MacLennan, 1994). In the 
extrafollicular pathway, B blasts migrate to the 
splenic bridging channels or junction zones at 
the border between the T zones and red pulp or 
the lymph node extramedullary cords, where 
they form foci of short-lived plasmablasts 
(MacLennan et al., 2003). These plasmablasts 
provide a wave of early antibody that, although 
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T follicular helper cells (Tfh cells) localize to follicles where they provide growth and selec-
tion signals to mutated germinal center (GC) B cells, thus promoting their differentiation 
into high affinity long-lived plasma cells and memory B cells. T-dependent B cell differen-
tiation also occurs extrafollicularly, giving rise to unmutated plasma cells that are impor-
tant for early protection against microbial infections. Bcl-6 expression in T cells has been 
shown to be essential for the formation of Tfh cells and GC B cells, but little is known 
about its requirement in physiological extrafollicular antibody responses. We use several 
mouse models in which extrafollicular plasma cells can be unequivocally distinguished from 
those of GC origin, combined with antigen-specific T and B cells, to show that the absence 
of T cell–expressed Bcl-6 significantly reduces T-dependent extrafollicular antibody re-
sponses. Bcl-6+ T cells appear at the T–B border soon after T cell priming and before GC 
formation, and these cells express low amounts of PD-1. Their appearance precedes that of 
Bcl-6+ PD-1hi T cells, which are found within the GC. IL-21 acts early to promote both 
follicular and extrafollicular antibody responses. In conclusion, Bcl-6+ T cells are necessary 
at B cell priming to form extrafollicular antibody responses, and these pre-GC Tfh cells can 
be distinguished phenotypically from GC Tfh cells.
© 2011 Lee et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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ing is comparable in both pathways, and up to 25% of the 
plasma cells found in splenic extrafollicular foci after standard 
TD immunization protocols are of GC origin (Sze et al., 2000).
In this study, we report the results of experiments from 
several different models in which we can distinguish antigen-
specific plasmablasts and/or antibodies of either extrafollicu-
lar or follicular origin. We show that Bcl-6–expressing T cells 
are essential for extrafollicular production of IgG1 in responses 
to the model protein antigens hen egg lysozyme (HEL) and 
NP-KLH (4[hydroxy-3-nitrophenyl] acetyl keyhole limpet 
hemocyanin) and for the production of Salmonella enterica–
specific IgG2c. Bcl-6–expressing helper T cells are initially 
situated at the interface between the B cell follicle and the 
T zone and, unlike Tfh cells located in the GC, do not ex-
press high levels of PD-1.
RESULTS AND DISCUSSION
Bcl-6–expressing PD-1lo CD3+ T cells are seen at the T–B 
border early in the course of an antibody response
We began by investigating whether Bcl-6 expression is con-
fined to GC T cells during T-dependent immune responses 
by assessing the distribution and kinetics of Bcl-6–expressing 
cells during a T-dependent response to sheep RBCs (SRBCs). 
In unimmunized mice, there were virtually no Bcl-6+ T cells 
detected outside rare background GCs (Fig. 1 A). Between 
days 2 and 3, CD3+ Bcl-6+ PD-1lo cells were seen at the T–B 
border. By day 7, CD3+ cells expressing higher amounts of 
Bcl-6 and PD-1 appeared within newly formed GCs (Fig. 1, 
B and C). As has been reported before (Haynes et al., 2007; 
Linterman et al., 2009a), and most were Bcl-6+ CD3+ PD-1hi 
T cells were rarely seen at sites other than the GC. We con-
clude that high expression of PD-1 identifies GC Tfh cells. 
Together, these results suggest that the T cells that interact 
with B cells at the outer T zone have up-regulated Bcl-6, raising 
the possibility that expression of Bcl-6 influences B cell commit-
ment to both the follicular and the extrafollicular pathways.
Bcl-6 expression in T cells boosts T-dependent 
extrafollicular antibody responses to a haptenated protein
To evaluate the influence of T cell–expressed Bcl-6 on the 
early antibody response to NP-KLH, we constructed mixed 
chimeras in which sublethally irradiated Rag1/ mice were 
reconstituted with 80% Bcl6/ CD45.2:20% Cd28/ CD45.1 
fetal liver. Cd28/ fetal liver cells help maintain the chime-
ras’ health and provide a source of Bcl-6+ B cells and T cells 
that cannot differentiate into effector cells, including Tfh cells. A 
control group was reconstituted with 80% Bcl6+/+ CD45.2:20% 
Cd28/ CD45.1 fetal liver.
Chimeric mice were immunized i.p. with NP-KLH in 
alum. 7 d after immunization, mice lacking functional Bcl-6–
expressing T cells did not form GC (Fig. 2, A and B) or Tfh 
cells (Fig. 2, C and D). This concurs with previously pub-
lished data showing that Bcl-6–expressing Tfh cells are required 
for the formation of GCs (Johnston et al., 2009; Nurieva et al., 
2009; Yu et al., 2009). Mice lacking functional Bcl-6–expressing 
T cells had an 50% reduction in switched Syndecan-1+ 
unmutated and generally of modest affinity, can be critical for 
protection against infection (Luther et al., 1997). Bcl-6 ex-
pression in T cells is required for the formation of T follicular 
helper cells (Tfh cells), which are essential to support GC re-
actions (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 
2009). Whether Bcl-6 expression in T cells is required for 
B cell differentiation along the extrafollicular pathway is 
still unknown.
Bcl-6 and Blimp-1 are important transcriptional regula-
tors of terminal differentiation of T and B cells; they are mu-
tually repressive, and their reciprocal abundance appears to 
specify one or other cell fate when two differentiation path-
ways are possible. In B cells, Bcl-6 is essential for the devel-
opment of GC B cells (Dent et al., 1997; Fukuda et al., 1997; 
Ye et al., 1997), whereas Blimp-1 is required for extrafollicu-
lar plasma cell formation (Shapiro-Shelef et al., 2003). T cells 
require Bcl-6 expression for up-regulation of CXCR5, the 
receptor for the chemokine CXCL13, which is produced by 
follicular DCs in B cell follicles and GC T cells themselves 
(Cyster et al., 2000; Kim et al., 2004). Coordinated down-
regulation of CXCR5 and up-regulation of CCR7 by T cells 
is required for the interactions at the T–B border that precede 
follicular migration (Cyster et al., 2000; Haynes et al., 2007). 
During this initial T–B cognate interaction, T cells provide 
signals that initiate Ig isotype switching (Toellner et al., 1996; 
Pape et al., 2003).
There is evidence to suggest that the nature of T cell help 
required to promote extrafollicular antibody responses may 
differ from that required to drive GC development. First, extra-
follicular responses occur in response to pure polysaccharide 
antigens in the absence of T cell help, whereas T-independent 
GCs are only found in exceptional circumstances (de Vinuesa 
et al., 2000). Second, although SAP (SLAM-associated pro-
tein) expression in T cells is required for differentiation of 
Tfh cells and GC B cells (Qi et al., 2008; Cannons et al., 
2010), extrafollicular antibody responses are less dependent 
on this adaptor molecule (Linterman et al., 2009b).
Although it is thought that Th1 and Th2 cells, which 
form in a Bcl-6–independent manner, can drive extrafollicu-
lar switched antibody responses, there is indirect evidence to 
suggest that Bcl-6 may play a role in these responses. Early 
antibody production is diminished in lymphocytic choriomen-
ingitis virus–infected mice expressing low levels of Bcl-6 in 
T cells as a consequence of Blimp-1 overexpression (Johnston 
et al., 2009). Also, in autoimmune lupus-prone MRL/Faslpr 
mice, T cells that share some but not all phenotypic markers 
of Tfh cells and are Bcl-6 dependent have been found in ex-
trafollicular foci, and they appear to promote autoantibody 
production (Odegard et al., 2008; Poholek et al., 2010). In 
contrast, the early antibody response to protein antigen was 
reported to be intact in irradiated Rag1/ mice reconstituted 
with Bcl-6–deficient bone marrow (Fukuda et al., 1997). 
However, it is difficult to distinguish follicular from extrafol-
licular origin of antibody because most immunization strate-
gies do not result in development of only one or the other 
pathway of B cell differentiation. Furthermore, isotype switch-
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caveat of these experiments is that the absence of Bcl-6 ex-
pression in 80% of the B cells may influence the extrafollicu-
lar plasma cell response, although Bcl-6–deficient B cells 
would be expected to give rise to enhanced rather than de-
creased plasma cell responses as the result of unopposed 
Blimp-1 expression.
To control for these possibilities and accurately quantify 
the number of EFPBs produced, we took advantage of the 
SWHEL adoptive transfer system. CD45.1 SWHEL transgenic 
B cells bearing a rearranged HEL-specific VDJH element tar-
geted into the IgH chain locus combined with an HEL-specific 
k L-chain transgene (Phan et al., 2003) were transferred i.v. 
into mixed Bcl6/ CD45.2:Cd28/ CD45.2 or Bcl6+/+ 
CD45.2:Cd28/ CD45.2 chimeric mice in combination 
with HEL protein conjugated to SRBC. Thus, transferred 
SWHEL B cells have an intact Bcl6 gene, can undergo class 
switching, and develop into both GC B cell and EFPB popu-
lations in response to HEL (Phan et al., 2003; Paus et al., 
2006). In this model, GC B cells and EFPBs can be identified 
by flow cytometry (Phan et al., 2003; Paus et al., 2006).
The development of HEL-binding, 
CD45.1 EFPBs and GC B cells was quanti-
fied 4.5 d after transfer. The gating strategies 
are shown in Fig. 3; GC B cells derived from 
transferred SWHEL cells are CD45.1 B220+ 
GL-7hi Fashi and HEL binding (Fig. 3 A). In 
the absence of Bcl-6–expressing T cells, the 
development of antigen-specific GC B cells 
was reduced to 10% of the numbers found 
in the presence of Bcl-6–expressing T cells 
(Fig. 3 B), which is consistent with the pre-
viously described lack of functional Tfh cells 
in these chimeric mice (Yu et al., 2009).
The EFPB response derived from 
donor SWHEL B cells can be measured by 
enumerating CD45.1+ B220lo intracellular 
HEL-bindinghi cells (Fig. 3 C; Phan et al., 
2003; Paus et al., 2006). In the absence of 
Bcl-6–expressing T cells, the percentage of 
EFPBs was reduced to 5% of that pro-
duced in the presence of Bcl-6–expressing 
T cells (Fig. 3 D). On day 5 of the SWHEL  
B cell response to HEL-SRBC, anti-HEL 
antibodies are produced exclusively by EFPBs 
(Paus et al., 2006). Quantification of serum 
anti-HEL IgM and IgG1 (the predominant 
(CD138+) plasma cells in the spleen (Fig. S1, A and B). NP-
specific IgG1 titers were reduced by >40-fold, and a more 
modest reduction in NP-specific IgM titers was also observed 
(Fig. 2 E). By day 7, few extrafollicular foci containing IgG1+ 
plasma cells were visible (Fig. 2 F) in the spleens of chimeras 
lacking Bcl-6 expression in T cells. Together, these results 
suggest that Bcl-6–expressing T cells are important for opti-
mal extrafollicular antibody responses to protein antigens.
Bcl-6–expressing T cells are required for the development 
of antigen-specific extrafollicular plasmablasts (EFPBs)
Although the aforementioned results suggest a role for Bcl-6 
in extrafollicular antibody responses, the origin of the anti-
body-producing cells cannot be precisely identified in this 
model. For example, an early wave of memory B cells that 
develops in parallel to the extrafollicular antibody response 
independently of GC, Bcl-6, ICOS (inducible T cell co-stim-
ulator), and IL-21 has been now described by several groups 
(Toyama et al., 2002; Inamine et al., 2005; Chan et al., 2009; 
Linterman et al., 2010; Zotos et al., 2010). Another potential 
Figure 1. Bcl-6+ PD-1lo CD4+ cells are seen at 
the T–B border after SRBC immunization.  
(A–C) Immunofluorescence stains of spleen sections 
from C57BL/6 mice at 0 (A), 3 (B), and 7 d (C) after 
SRBC immunization. Boxed areas indicate the loca-
tion of the zoomed-in images on the right, in the 
same order (from top to bottom). These data are rep-
resentative of two independent experiments with 
four mice per experiment. F, follicle; T, T zone.
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and survival (Linterman et al., 2010; Zotos et al., 2010). IL-21 
also promotes Blimp-1 expression and plasma cell formation 
(Ozaki et al., 2004). We compared side by side the effects 
of IL-21 in the course of a SWHEL B cell–derived GC and 
EFPB response.
SWHEL B cells sufficient or deficient for the IL-21R 
(Il21r/) were transferred to CD45.1 congenic C57BL/6 
mice, which were immunized with HEL2x-SRBC (Fig. 4 A). 
HEL2x is a mutant HEL protein that binds the SWHEL BCR 
with lower affinity. In the absence of IL-21R signaling, the 
production of GC B cells was reduced to 12% of the levels 
seen with IL-21R–sufficient donor cells at day 4.5 (Fig. 4 B), 
which is consistent with the described dependency of GC B 
cells on IL-21. The development of EFPBs was also impaired 
in the absence of IL-21R signaling, with only around 10% of 
the cell numbers seen with IL-21R–sufficient donor cells at 
day 4.5 (Fig. 4 C). In the absence of IL-21–mediated signal-
ing, the extrafollicular response peaked 12 h later, on day 5. 
At this time point, there was a fourfold reduction in the 
number of EFPBs in the absence of IL-21R (Fig. 4 C). The 
GC and EFPB responses to SRBCs elicited by the host 
CD45.1 Il21r+/+ B cells were comparable in both groups of 
adoptively transferred mice (Fig. S2, A and B).
The effects of IL-21 deficiency were apparent after 4 d in 
the course of both follicular and extrafollicular antibody re-
sponses (Fig. 4, A–C), suggesting that IL-21 produced by 
T cells acts at the stage of T–B interaction to enhance and 
accelerate B cell activation before their differentiation into 
either GC cells or extrafollicular plasma cells. IL-21 has re-
cently been shown to promote GC B cell proliferation and 
survival, at least in part through maximizing Bcl-6 expression 
in B cells (Linterman et al., 2010; Zotos et al., 2010). Our 
findings extend this effect of IL-21 to extrafollicular antibody 
responses and are consistent both with reports that IL-21 also 
promotes Blimp-1 expression and plasma cells accumulate 
when overexpressed (Ozaki et al., 2004) and with the paucity 
of extrafollicular plasma cells 7 d after NP-KLH immuniza-
tion in IL-21R and IL-21 knockout mice (Zotos et al., 2010).
Bcl-6–expressing T cells are required for the development 
of class-switched extrafollicular plasma cells  
in S. enterica infection
We next sought to examine whether the requirement for 
Bcl-6 expression in T cells also occurs in the context of an 
extrafollicular antibody response to S. enterica infection, which 
has been shown to occur independently of IL-21 (Linterman 
et al., 2010). The immune response to infection with S. enterica 
induces a potent extrafollicular plasma cell response, result-
ing in the production of T-independent IgM antibodies and 
T-dependent class switching of B cells to produce IgG2a 
(IgG2c in C57BL/6 mice) and IgG2b antibodies (Cunningham 
et al., 2004; Linterman et al., 2009a). T dependency has 
been previously demonstrated by the absence of S. enterica–
specific switched antibody responses in mice lacking CD28 
(Cunningham et al., 2004; Linterman et al., 2009a). The GC 
response is considerably delayed, developing between days 20 
isotype found in SWHEL B cell responses to HEL-SRBC; 
Phan et al., 2003) antibodies revealed negligible production 
of anti-HEL IgM in the mice lacking Bcl-6–expressing 
T cells (0.18% of the titer found in mice with Bcl-6–expressing 
T cells; Fig. 3 E) with no detectable anti-HEL IgG1 anti-
bodies. These results demonstrate a requirement of Bcl-6– 
expressing T cells for the production of switched and 
unswitched EFPBs in response to a TD antigen.
IL-21 acts early to promote follicular and extrafollicular 
antibody responses
IL-21 is produced by Tfh cells and acts directly on B cells to 
maximize Bcl-6 expression and promote GC B cell growth 
Figure 2. Reduced plasma cell responses to NP-KLH in the absence 
of T cell–expressed Bcl-6. (A–D) Representative flow cytometric con-
tour plots (A and C) and quantification (B and D) of GC B cells identified 
as B220+ PNAhi splenocytes (A and B) and Tfh cells identified as CXCR5hi 
PD-1hi (gated on CD4+ cells; C and D) from 80% Bcl6/ CD45.2:20% 
Cd28/ CD45.1 (i.e., effector T cells lack Bcl-6; Tc Bcl6/) or control 
80% Bcl6+/+ CD45.2:20% Cd28/ CD45.1 (Tc Bcl6+/+) fetal liver chimeric 
mice immunized 7 d earlier with NP-KLH. (E) NP-specific IgG1 and NP-
specific IgM antibodies in the same chimeric mice. (F) Photomicrographs 
of spleen sections stained with B220 (follicles; blue) and IgG1 (plasma 
cells; brown). These data are representative of two independent experi-
ments with five mice per group in each cohort.
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results suggest that switched antibody responses 
to S. enterica require help from T cells in a Bcl-6–
dependent manner.
Our data so far suggest that Bcl-6–expressing 
T cells rather than conventional Th1 cells are 
required for extrafollicular antibody responses. 
To confirm the presence of functional S. enterica–
specific Th1 cells in mice lacking Bcl-6 expression 
in T cells, we investigated bacterial clearance, which 
has been shown to be critically dependent on the 
presence of functional Th1 cells (Hess et al., 1996). 
Although bacterial counts were increased by nearly 
2 logs in nonchimeric Cd28/ mice that lack 
Th1 cells (Fig. 5 H), lack of Bcl-6 expression in 
T cells did not alter bacterial load in the livers of 
chimeric mice 12 d after infection (Fig. 5 G).
Next, we investigated when and where Bcl-6+ 
T cells appear during the response to S. enterica. A 
population of CD3+ Bcl-6+ PD-1/lo cells was de-
tected at that outer T zone on day 4 after infection 
(Fig. 6, A and C), with total numbers increasing 10-fold 
above background. This is consistent with our previous find-
ing of a 20-fold increase in numbers of IgG2c switched plasma 
cells as early as day 4 after S. enterica infection (Cunningham 
et al., 2007). At this time point (day 4), CD3+ Bcl-6+ PD-1hi 
cells were absent (Fig. 6, A and C), but they became visible 
35 d after immunization, when S. enterica–induced GCs 
appear, and they were located within the GC (Fig. 6 B). 
Together, these results highlight a necessary role for T cell–
expressed Bcl-6 soon after infection to promote switching. 
Given that the IgG2c response occurs normally in the absence 
of IL-21 but requires IFN-, it is likely that early Th1 cells 
producing IFN- up-regulate Bcl-6 that facilitates migration 
to the T–B border and thus cognate interaction with antigen-
primed B cells.
The expression of PD-1 and CXCR5 was evaluated 
on effector (CD4+ CD44hi) cells. On day 7, at which time 
S. enterica fails to induce GCs regardless of Bcl-6 expression, 
PD-1hi CXCR5hi GC Tfh cells (Fig. 6 D, red gate) that were 
seen at background levels in PBS-immunized chimeras 
and 35 after infection (Cunningham et al., 2007). It has also 
been established that IFN-–producing Th1 cells are responsi-
ble for bacterial clearance, starting on week 2 after immuni-
zation (Hess et al., 1996). Thus, S. enterica infection is an ideal 
model in which to investigate whether Bcl-6–expressing T cells 
rather than conventional Th1 cells are required to drive the 
extrafollicular plasma cell response without the potential in-
terference of GC B cell–derived antibodies or GC Tfh cells.
Bcl6+/+ CD45.2:Cd28/ CD45.1 or Bcl6/ CD45.2: 
Cd28/ CD45.1 mixed fetal liver chimeric mice were in-
fected i.p. with S. enterica. As shown previously (Cunningham 
et al., 2007), this immunization did not increase GC cells 
above background 7 d after infection (Fig. 5, A and B). At 
this same time point, anti–S. enterica IgM and IgG2c titers 
were measured by ELISA. Bcl-6 deficiency in T cells did not 
reduce the production of specific IgM (Fig. 5 C) but signifi-
cantly reduced the titer of anti–S. enterica IgG2c antibodies 
(Fig. 5 D). This mirrored the requirement of CD28 for 
specific IgG2c but not IgM production in a cohort of 
C57BL/6 Cd28/ mice (Fig. 5, E and F). Together, these 
Figure 3. Development of HEL-specific EFPBs cells is 
greatly impaired in the absence of T cell–expressed Bcl-6. 
(A–D) Representative flow cytometric contour plots (A and C) 
and quantification (B and D) of SWHEL GC B cells identified as 
B220+ GL-7+ Fas+ HEL-binding CD45.1 cells (A and B) and 
EFPBs identified as CD45.1+ B220lo intracellular HEL-binding 
cells (C and D) in CD45.2 chimeric mice sufficient (Tc Bcl6+/+) 
or deficient (Tc Bcl6/) in Bcl-6–expressing T cells 4.5 d 
after adoptive transfer of SWHEL B cells and HEL-SRBC immu-
nization. Control (HEL) mice received SWHEL B cells and were 
immunized with SRBCs that had not been conjugated to  
HEL. (E) HEL-specific antibody titers in the same HEL-SRBC–
immunized chimeric mice. These data are representative of 
two independent experiments with five mice per group im-
munized with HEL-SRBC and two mice per group in the HEL-
only control group for each independent experiment.
1382 Bcl-6+ T cells drive extrafollicular responses | Lee et al.
mice (Fig. 1 B), OT-II T cells had up-regulated 
PD-1 on day 2, but the levels were approximately 
threefold lower than those of day 4 OT-II cells 
from immunized recipient mice analyzed on the 
same day (Fig. 7 B). CXCR5 expression did not 
increase significantly from day 2 to 4 (Fig. 7 B).
On day 5.5 after immunization, spleens were 
harvested, and distinct HEL-specific GC B cells 
and extrafollicular plasma cells were identified by 
flow cytometry on the basis of size and differential 
expression of B220, CXCR5, and HEL binding (Fig. 7 C). 
Recipients of Bcl6/ OT-II cells showed a parallel and com-
parable reduction in both GCs and EFPBs (Fig. 7, D–F). 
Staining with PD-1 and CXCR5 demonstrated the absence 
of PD-1hi CXCR5hi Tfh cells among OT-II Bcl6/ T cells 
on day 5.5 (Fig. 7, G and H). These results confirm that 
T cell–expressed Bcl-6 plays a role in B cells differentiating 
along the extrafollicular pathway. GL-7 has been recently de-
scribed as a marker of GC Tfh cells (Yusuf et al., 2010). The 
appearance of GL-7hi CD4+ cells among OT-II cells lacking 
Bcl-6 expression (these cells expressed low amounts of PD-1 
and CXCR5; Fig. S5) suggests that GL-7hi cells are a hetero-
geneous population comprised of activated CD4+ cells other 
than GC Tfh cells.
We observed significantly fewer switched EFPBs in the 
absence of T cell–expressed Bcl-6 across all experimental sys-
tems used in this study. A previous report described normal 
antibody titers in the first 2 wk after immunization of chi-
meric mice lacking Bcl-6 in T and B cells (Toyama et al., 2002). 
It is possible that the requirement for Bcl-6+ T cells may be 
overcome by signals from other cells; B cells differentiating 
along the extrafollicular route are also known to be boosted 
by IL-6 and/or APRIL (a proliferation-inducing ligand)-
producing cells that colocalize with EFPBs (Mohr et al., 
2009). It is also conceivable that the plasma cells and anti-
bodies detected on day 14 in mice lacking Bcl-6+ T cells have 
arisen from an alternative route of differentiation. Indeed, 
several groups have reported a third B cell differentiation route 
into early memory B cells that is GC, ICOS, Bcl-6, and 
(Fig. 6 D, top left; and Fig. S4 C) were low or absent after 
S. enterica immunization in all chimeras. Immunized chimeras 
lacking Bcl-6 expression in T cells selectively lacked a PD-1lo 
CXCR5+ population (Fig. 6 D, blue gate; and Fig. S4 B), 
which is likely to correlate with those cells shown in Fig. 1 A 
that localize to the T–B border and prime B cells. Non-Tfh effec-
tors identified as CD4+ CD44hi CXCR5 PD-1 (Fig. 6 D, 
green gate; and Fig. S4 A) were equally represented in both 
sets of chimeras, irrespective of T cell expression of Bcl-6. 
Together, these data suggest that CD4+ CD44hi CXCR5+ 
Bcl-6+ PD-1lo cells may be important for the initiation of an 
extrafollicular antibody response.
Bcl-6 is required for a T and B cell antigen–specific 
extrafollicular antibody response
A potential confounding factor in the aforementioned ex-
periments is the increased proportion of activated Bcl6/ 
CD44hi CD4+ cells in mixed chimeras reconstituted with 
Bcl6/ fetal liver (Fig. S3). To overcome this issue, we 
performed adoptive transfers of 105 naive CD45.2 OT-II 
cells that express a transgenic TCR specific for OVA pep-
tide 323–339 and were either deficient or sufficient in Bcl-6 
into CD45.1 Cd28/ mice. Recipient mice also received 
105 SWHEL B cells and were immunized with HEL-OVA 
conjugates. We first compared the phenotype of Bcl-6– 
sufficient effector (CD44hi) OT-II cells at the B cell priming 
stage (pre-GC Tfh, day 2) and the stage in which GC Tfh 
cells are readily visible (day 4; Fig. 7, A–C). Concordant with 
the immunohistochemistry data from SRBC-immunized 
Figure 4. IL-21 influences GC and EFPB responses 
from the early stages of B cell activation. (A) Represen-
tative flow cytometric dot plots showing HEL binding versus 
B220 staining of Il21r+/+ or Il21r/ CD45.2 SWHEL B cells at 
the indicated days after transfer into congenic (CD45.1) 
C57BL/6 recipients immunized with HEL2x-SRBC at the time 
of transfer. The gates in each plot are drawn around GC  
B cells (B220hi; right) and EFPBs (B220lo; left). Numbers in 
plots indicate the percentage of HEL-binding CD45.2 SWHEL 
cells out of total splenocytes. (B and C) Number of SWHEL GC 
B cells (B) and EFPBs (C) in the same mice using the gates 
shown in A. These data are representative of two indepen-
dent experiments with three mice per group per time point. 
The p-values were calculated using two-way analysis of 
variance that interrogates the variance over the entire time 
course between the two groups of mice receiving either 
Il21r+/+ or Il21r/ SWHEL B cells.
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absence of Bcl-6 expression by CD4+ T cells, the 
switched antibody responses to all antigens are 
completely abrogated, including the extrafol-
licular IgG2a response to S. enterica, against 
which only antigen-specific IgM, of probable 
T-independent origin, is maintained.
Our finding that T cell–expressed Bcl-6 
acts at the time of T–B interaction does not ex-
clude the possibility that Bcl-6 expression in 
T cells may also be required at the stage of plas-
mablast growth in extrafollicular foci. CXCR5lo 
CXCR4hi CD4+ T cells have been found in 
splenic extrafollicular foci of autoimmune MRL/
Faslpr mice (Odegard et al., 2008), and these are 
also Bcl-6 dependent (Poholek et al., 2010). 
This work suggests that Tfh are even more het-
erogeneous than we thought. Bcl-6+ T cells in the outer 
T zones appear competent to help B cells differentiate along 
either the follicular or extrafollicular pathway. This highlights 
the need for refining the nomenclature of B follicular helper 
T cells. As has been previously proposed (McHeyzer-Williams 
et al., 2009), pre-GC Tfh cells can be used to refer to T cells 
that prime B cells at the T–B border, which are shown here to 
be PD-1lo/int Bcl-6+, whereas GC Tfh cells can be used to refer 
to those CD4+ T cells located within GCs, which are generally, 
albeit not universally, PD-1hi.
MATERIALS AND METHODS
Mice and immunizations. C57BL/6, Cd28/ mice and Bcl6/ mice 
backcrossed for 14 generations into the C57BL/6 genetic background were 
maintained by the Australian National University Bioscience Services in spe-
cific pathogen–free conditions and had access to food and water ad libitum. 
SWHEL CD45.1 mice, which carry a Vk10k light chain transgene and a 
knocked in VH10 Ig heavy chain in place of the JH segments of the endoge-
nous IgH gene that encode a high-affinity antibody for HEL, were obtained 
from the laboratory of R. Brink (Garvan Institute, Sydney, New South 
Wales, Australia) and maintained by the Australian National University Biosci-
ence Services. SWHEL Il21r+/+ CD45.2, SWHEL Il21r/ CD45.2, and recipient 
IL-21 independent (Toyama et al., 2002; Inamine et al., 2005; 
Chan et al., 2009; Linterman et al., 2010; Zotos et al., 2010).
Our data establish that Bcl-6 expression enables T cells to 
provide effective help to B cells for both follicular and extra-
follicular antibody responses to protein antigens. PD-1 ex-
pression distinguishes outer T zone PD-1lo/inti Bcl-6+ pre-GC 
Tfh cells from the PD-1hi Bcl-6+ Tfh cells that appear within 
the GC (GC Tfh cells). Bcl-6 has been shown to be critical 
for up-regulation of CXCR5 and down-regulation of CCR7 
(Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009), 
which are required for T and B cell localization to the T–B 
border (Cyster et al., 2000; Haynes et al., 2007). Thus, ex-
pression of Bcl-6 appears important to facilitate the initial T 
and B cell encounter at this location that results in the provi-
sion of T cell help required to initiate T-dependent B cell 
differentiation and Ig isotype switching. Indeed and contrary 
to common belief, there is evidence that production of >99% 
of switch transcripts occurs at this time and therefore pre-
cedes GC formation (Toellner et al., 1996; Pape et al., 2003). 
In agreement with this, we have shown here that in the 
Figure 5. IgG2c extrafollicular antibody responses 
to S. enterica are impaired in the absence of T cell–
expressed Bcl-6. (A) Representative flow cytometric 
plots showing Fas versus GL-7 stains from spleens of 
80% Bcl6/ CD45.2:20% Cd28/ CD45.1 (Tc Bcl6/) 
chimeras or control 80% Bcl6+/+ CD45.2:20% Cd28/ 
CD45.1 (Tc Bcl6+/+) fetal liver chimeric mice injected 7 d 
previously with S. enterica; oval gates identify GC B cells. 
(B) Bar graphs show the number of splenic GC B cells in 
the same mice (left) and a group of Cd28/ and control 
Cd28+/+ mice infected with S. enterica at the same time 
(right). (C–F) S. enterica–specific IgM (C and E) and IgG2c 
(D and F) antibody titers 7 d after S. enterica infection in 
the same fetal liver chimeric mice as in A (C and D) or 
Cd28/ and Cd28+/+ mice (E and F). (G and H) S. enterica 
CFUs in livers 12 d after infection of the chimeras (G) and 
nonchimeric Cd28/ and Cd28+/+ mice (H). These data 
are representative of three independent experiments 
with three mice per PBS-only control groups and five to 
seven mice per S. enterica–infected groups.
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Figure 6. Bcl-6+ T cells induced by S. enterica infection are PD-1lo and locate to the T–B border. (A and B) Immunofluorescence stains of 
spleen sections from C57BL/6 immunized 4 (A) or 35 d (B) previously with S. enterica. Boxed areas indicate the location of the zoomed-in images on the 
right, in the same order (from top to bottom). (C) Quantification of CD3+ Bcl-6+ PD-1lo (left) and CD3+ Bcl-6+ PD-1hi (right) cells in the T–B border and GCs 
at the indicated times after immunizations. (D) Representative flow cytometric plots showing PD-1 versus CXCR5 expression on effector/memory CD4+ 
CD44hi cells from 80% Bcl6/ CD45.2:20% Cd28/ CD45.1 (Tc Bcl6/) chimeras or control 80% Bcl6+/+ CD45.2:20% Cd28/ CD45.1 (Tc Bcl6+/+) fetal 
liver chimeric mice injected 7 d previously with S. enterica (green gate, non-Tfh effectors; blue gate, PD-1lo Tfh cells; and red gate, PD-1hi Tfh cells). These 
data are representative of two independent experiments with four mice per group in each cohort.
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liver cells; and for recipients of CD45.1 SWHEL 
B cells, 80% Bcl6/ CD45.2:20% Cd28/ 
CD45.2 and control 80% Bcl6+/+ CD45.2:20% 
Cd28/ CD45.2 fetal liver cells. All groups 
were maintained on antibiotics for 6 wk, and 
experiments were performed 8 wk after recon-
stitution to allow for full reconstitution of the immune system.
S. enterica inoculations and liver bacterial counts. S. enterica serovar 
Dublin strain SL5631 (Segall and Lindberg, 1991) was grown in Luria-Bertani 
medium overnight. Mice were inoculated with 106 CFUs from a log-phase 
culture administered i.p. in PBS, with control mice receiving PBS only. 
Liver bacterial load was measured at day 12 after infection by homogenizing 
organs, plating serial dilutions in PBS onto Luria-Bertani agar, and incubat-
ing at 37°C overnight. For experiments with S. enterica serovar Typhimurium 
strain SL3261, mice were immunized i.p. with 5 × 105 bacteria in PBS.
ELISA. ELISAs were used to quantify serum titers of anti-HEL, anti-NP, and 
anti–S. enterica antibodies. To quantify anti-HEL and anti–S. enterica antibodies, 
96-well plates were coated with either 1 µg/ml HEL protein or 250 µg/ml 
S. enterica lysate prepared as previously described (Valentine et al., 1998) in 0.05 M 
carbonate buffer (Na2CO3 + NaHCO3, pH 9.6) overnight and subsequently 
blocked with PBS/1% BSA. Serum was serially diluted onto the 96-well 
plates in PBS/1% BSA/0.05% Tween 20 buffer and incubated for 2 h at 37°C. 
C57BL/6 CD45.1 mice were maintained in the animal facility at the Garvan 
Institute. For experiments involving SWHEL mice, 105 SWHEL B cells were 
transferred into recipients, which were simultaneously immunized i.v. with 
2 × 108 SRBCs conjugated to HEL or HEL2x protein (Paus et al., 2006). For 
experiments involving NP-KLH, immunizations with hapten 4(hydroxy-3-
nitrophenyl) acetyl (NP) coupled to keyhole limpet hemocyanin (KLH) at a 
molar ratio of 16:1 were performed. 100 µg NP-KLH was precipitated in 
alum and injected i.p. HEL-OVA immunizations are described in the OT-II 
adoptive transfer section. All procedures were performed with appropriate 
ethical and legal approval by the Australian National University’s Animal 
Experimentation Ethics Committee.
Generation of fetal liver chimeras. Recipient Rag1/ mice were irradi-
ated with 500 Rad and reconstituted via i.v. injection with 2 × 106 donor fetal 
liver–derived hematopoietic stem cells. Mice were reconstituted with the 
following combinations of fetal liver cells: for S. enterica infection and NP-
KLH immunization experiments, 80% Bcl6/ CD45.2:20% Cd28/ 
CD45.1 and control 80% Bcl6+/+ CD45.2:20% Cd28/ CD45.1 fetal 
Figure 7. Development of HEL-specific 
GC and EFPBs is impaired in the absence 
of OVA-specific T cells expressing Bcl-6. 
Naive OT-II Bcl6+/+ or OT-II Bcl6/ with or 
without SWHEL B cells were transferred i.v. 4 h 
apart into Cd28/ CD45.1 recipient mice, 
which were then immunized with HEL-OVA 
and/or OVA in alum i.p. (A and B) CXCR5 ver-
sus PD-1 phenotype of OT-II Bcl6+/+ cells on 
day 2 or 4 after transfer into mice immunized 
with OVA in alum. Gating strategy to identify 
naive versus activated donor OT-II cells on  
day 2 or 4 after transfer (A) and representa-
tive flow cytometric plots, histograms, and bar 
graphs showing PD-1/ CXCR5 expression on 
naive (CD44lo) and activated (CD44hi) OT-II 
cells on either day 2 or 4 after adoptive cell 
transfer and immunization, analyzed on the 
same day (B). (C) Representative flow cyto-
metric plots showing the gating strategy to 
identify donor-origin SWHEL GC B cells (CD45.2 
B220hi HEL-bindinghi CXCR5hi small forward 
scatter [FSC]) and EFPBs (CD45.2 B220lo HEL-
bindinglo CXCR5lo large forward scatter) in the 
spleens of Cd28/ CD45.1 recipient mice 5.5 d 
after adoptive transfer. (D–F) Flow cytometric 
profiles (D) and quantification of SWHEL  
EFPBs (E) and GC B cells (F) in the same  
recipient mice 5.5 d after immunization with 
HEL-OVA. (G and H) Representative flow cyto-
metric plot showing gating strategy (G) and 
quantification (H) of donor-origin Tfh cells 
identified as CXCR5hi PD-1hi CD45.2 (gated on 
CD4+ cells) after transfer of OT-II Bcl6+/+ or 
OT-II Bcl6/ T cells. These data are represen-
tative of two independent experiments with 
three to six mice per group.
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using anti-CD3 (BD) followed by anti–Armenian hamster Cy5 (Jackson 
ImmunoResearch Laboratories, Inc.). For Bcl-6, anti–mouse Bcl-6 (Santa 
Cruz Biotechnology, Inc.) was followed by donkey anti–rabbit FITC (Jackson 
ImmunoResearch Laboratories, Inc.) and then Alexa Fluor 488–conjugated 
goat anti-FITC (Invitrogen). PD-1 was stained with purified anti–PD-1 
(BioLegend) followed by anti–rat Cy3 (Jackson ImmunoResearch Laborato-
ries, Inc.). For AID, anti–mouse AID (eBioscience) was followed by bio-
tinylated anti-rat IgG, and then streptavidin-HRP conjugates (Zymed) 
were followed by TSATM tetramethylrhodamine (PerkinElmer). Stained 
sections were mounted in Fluoromount-G (SouthernBiotech) and ana-
lyzed with a confocal laser-scanning microscope (DMRXA2; Leica; SRBC 
experiments) or a laser-scanning confocal microscope (LSM510; Carl 
Zeiss) with a microscope (AxioVert 100M; Carl Zeiss) using a 40× objec-
tive. The latter images were subsequently analyzed on the LSM Image 
Browser (Carl Zeiss).
Quantification of cells in tissue sections. Quantification of Bcl-6+ CD3+ 
PD-1hi/lo cells was performed as follows. 10 T zone areas were randomly selected. 
For each image, the number of CD3+ Bcl-6+ cells and their PD-1 status (bright/
intermediate or negative) was quantified, and the total number of cells in each 
spleen was calculated as described previously (Cunningham et al., 2007). Cell 
numbers and densities were estimated using point counting, and counts were ad-
justed for the different sizes of the spleens seen throughout the study by multi-
plying the cells/cubic millimeter by the mass of the spleen.
Statistical analysis. Two-way analysis of variance was used to interrogate 
whether IL-21R signaling was a significant contributor to variance over a 
time course (Fig. 4, B and C). For other experiments, the nonparametric 
Mann-Whitney test (U test) was used.
Online supplemental material. Fig. S1 demonstrates that splenic switched 
plasma cells are reduced in mice lacking Bcl-6 expression in T cells in fetal 
liver chimeric mice immunized 7 d earlier with NP-KLH. Fig. S2 shows host-
derived GC and EFPB responses 5 d after SRBC immunization. Fig. S3 shows 
that there is an increase in the proportion of effector cells among Bcl6/ 
T cells from mixed chimeric mice. Fig. S4 shows that there is a decrease in 
the numbers of PD-1lo CD4+ cells after S. enterica infection. Fig. S5 shows 
that PD-1hi cells but not GL-7hi cells fail to form in the absence of OT-II 
cell–expressed Bcl-6 after OVA immunization. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20102065/DC1.
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